FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2058798889> ?p ?o ?g. }

• W2058798889 endingPage "37" @default.
• W2058798889 startingPage "32" @default.
• W2058798889 abstract "Purposes This substudy aimed to examine the changes in biomarkers for cardiac injury in patients who received neoadjuvant 5-fluorouracil, epirubicin, cyclophosphamide with concurrent celecoxib (FEC-C). Methods Thirty-four female patients with histologically confirmed locally advanced breast cancer preoperatively received 3 cycles of FEC-C (500 mg/m 2 , 75 mg/m 2 , 500 mg/m 2 ) with concurrent celecoxib (400 mg bid). Blood samples were drawn from patients on day (D) 0, D3, D21, D42, and D63 (end of therapy), and the serum levels of lactate dehydrogenase (LDH) and plasma levels of cardiac troponin I (cTnI) and N-terminal prohormone brain-type natriuretic peptide (NT-proBNP) were measured with commercially available test kits. Results All patients tolerated this regimen well. Neither life-threatening toxicity nor clinical symptoms of cardiac damage were observed. Serum LDH increased significantly from baseline after 3 cycles of FEC-C (p<0.0001), but the change was possibly brought about by chemotherapy-induced liver derangement. However, NT-proBNP decreased significantly (p=0.009), while cTnI increased nonsignificantly (p=0.078) after 3 cycles of FEC-C compared to baseline, although this increase was still regarded as normal. Conclusions Short-term use of the FEC-C regimen has proven to be effective in locally advanced breast cancer, with an acceptable cardiac safety profile." @default.
• W2058798889 created "2016-06-24" @default.
• W2058798889 creator A5015689398 @default.
• W2058798889 creator A5028346592 @default.
• W2058798889 creator A5069258183 @default.
• W2058798889 creator A5087060680 @default.
• W2058798889 date "2013-01-01" @default.
• W2058798889 modified "2023-10-03" @default.
• W2058798889 title "Acceptable Cardiac Safety Profile of Neoadjuvant 5-Fluorouracil, Epirubicin, Cyclophosphamide and Celecoxib (FEC-C) for Breast Cancer: A Subanalysis of Biomarkers for Cardiac Injury" @default.
• W2058798889 cites W1975826537 @default.
• W2058798889 cites W1979350780 @default.
• W2058798889 cites W1980038534 @default.
• W2058798889 cites W2001646586 @default.
• W2058798889 cites W2010188885 @default.
• W2058798889 cites W2018317269 @default.
• W2058798889 cites W2028971149 @default.
• W2058798889 cites W2033400183 @default.
• W2058798889 cites W2042276084 @default.
• W2058798889 cites W2055491575 @default.
• W2058798889 cites W2059463577 @default.
• W2058798889 cites W2073912429 @default.
• W2058798889 cites W2087179076 @default.
• W2058798889 cites W2089320092 @default.
• W2058798889 cites W2099643651 @default.
• W2058798889 cites W2123578563 @default.
• W2058798889 cites W2133528707 @default.
• W2058798889 cites W2137942213 @default.
• W2058798889 cites W2146087823 @default.
• W2058798889 cites W2152573492 @default.
• W2058798889 cites W2158968701 @default.
• W2058798889 cites W2160843447 @default.
• W2058798889 cites W2161229145 @default.
• W2058798889 cites W2322659317 @default.
• W2058798889 cites W2336169581 @default.
• W2058798889 cites W4253462034 @default.
• W2058798889 doi "https://doi.org/10.5301/jbm.5000012" @default.
• W2058798889 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23592005" @default.
• W2058798889 hasPublicationYear "2013" @default.
• W2058798889 type Work @default.
• W2058798889 sameAs 2058798889 @default.
• W2058798889 citedByCount "3" @default.
• W2058798889 countsByYear W20587988892017 @default.
• W2058798889 countsByYear W20587988892018 @default.
• W2058798889 countsByYear W20587988892020 @default.
• W2058798889 crossrefType "journal-article" @default.
• W2058798889 hasAuthorship W2058798889A5015689398 @default.
• W2058798889 hasAuthorship W2058798889A5028346592 @default.
• W2058798889 hasAuthorship W2058798889A5069258183 @default.
• W2058798889 hasAuthorship W2058798889A5087060680 @default.
• W2058798889 hasConcept C115725540 @default.
• W2058798889 hasConcept C121608353 @default.
• W2058798889 hasConcept C126322002 @default.
• W2058798889 hasConcept C126894567 @default.
• W2058798889 hasConcept C141071460 @default.
• W2058798889 hasConcept C143998085 @default.
• W2058798889 hasConcept C181199279 @default.
• W2058798889 hasConcept C185592680 @default.
• W2058798889 hasConcept C2776467144 @default.
• W2058798889 hasConcept C2776694085 @default.
• W2058798889 hasConcept C2776755627 @default.
• W2058798889 hasConcept C2777318727 @default.
• W2058798889 hasConcept C2778233292 @default.
• W2058798889 hasConcept C2780456651 @default.
• W2058798889 hasConcept C2780835546 @default.
• W2058798889 hasConcept C2781413609 @default.
• W2058798889 hasConcept C500558357 @default.
• W2058798889 hasConcept C530470458 @default.
• W2058798889 hasConcept C55493867 @default.
• W2058798889 hasConcept C71924100 @default.
• W2058798889 hasConcept C90924648 @default.
• W2058798889 hasConceptScore W2058798889C115725540 @default.
• W2058798889 hasConceptScore W2058798889C121608353 @default.
• W2058798889 hasConceptScore W2058798889C126322002 @default.
• W2058798889 hasConceptScore W2058798889C126894567 @default.
• W2058798889 hasConceptScore W2058798889C141071460 @default.
• W2058798889 hasConceptScore W2058798889C143998085 @default.
• W2058798889 hasConceptScore W2058798889C181199279 @default.
• W2058798889 hasConceptScore W2058798889C185592680 @default.
• W2058798889 hasConceptScore W2058798889C2776467144 @default.
• W2058798889 hasConceptScore W2058798889C2776694085 @default.
• W2058798889 hasConceptScore W2058798889C2776755627 @default.
• W2058798889 hasConceptScore W2058798889C2777318727 @default.
• W2058798889 hasConceptScore W2058798889C2778233292 @default.
• W2058798889 hasConceptScore W2058798889C2780456651 @default.
• W2058798889 hasConceptScore W2058798889C2780835546 @default.
• W2058798889 hasConceptScore W2058798889C2781413609 @default.
• W2058798889 hasConceptScore W2058798889C500558357 @default.
• W2058798889 hasConceptScore W2058798889C530470458 @default.
• W2058798889 hasConceptScore W2058798889C55493867 @default.
• W2058798889 hasConceptScore W2058798889C71924100 @default.
• W2058798889 hasConceptScore W2058798889C90924648 @default.
• W2058798889 hasIssue "1" @default.
• W2058798889 hasLocation W20587988891 @default.
• W2058798889 hasLocation W20587988892 @default.
• W2058798889 hasOpenAccess W2058798889 @default.
• W2058798889 hasPrimaryLocation W20587988891 @default.
• W2058798889 hasRelatedWork W135948836 @default.
• W2058798889 hasRelatedWork W1969729309 @default.

• next